Los Angeles Capital Management LLC Fibrogen Inc Transaction History

Los Angeles Capital Management LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 05, 2021	SELL	$31.0 - $55.72 $729,833 - $1.31 Million	-23,543 Closed	0 $0
Q4 2020 Feb 04, 2021	SELL	$37.09 - $48.97 $185 - $244	-5 Reduced 0.02%	23,543 $873,000
Q3 2020 Nov 02, 2020	SELL	$40.47 - $45.5 $202 - $227	-5 Reduced 0.02%	23,548 $968,000
Q2 2020 Aug 05, 2020	BUY	$32.57 - $42.83 $61,720 - $81,162	1,895 Added 8.75%	23,553 $954,000
Q1 2020 May 04, 2020	BUY	$23.3 - $45.96 $504,631 - $995,401	21,658 New	21,658 $753,000
Q2 2019 Jul 29, 2019	SELL	$35.13 - $55.53 $1.1 Million - $1.74 Million	-31,362 Closed	0 $0
Q1 2019 Apr 25, 2019	BUY	$42.83 - $59.91 $46,470 - $65,002	1,085 Added 3.58%	31,362 $1.71 Million
Q4 2018 Feb 11, 2019	BUY	$37.97 - $60.16 $370,283 - $586,680	9,752 Added 47.51%	30,277 $1.4 Million
Q3 2018 Nov 05, 2018	SELL	$56.3 - $67.25 $226,326 - $270,345	-4,020 Reduced 16.38%	20,525 $1.25 Million
Q2 2018 Jul 31, 2018	SELL	$44.9 - $64.95 $19,307 - $27,928	-430 Reduced 1.72%	24,545 $1.54 Million
Q1 2018 Apr 27, 2018	BUY	$45.35 - $61.65 $1.13 Million - $1.54 Million	24,975 New	24,975 $1.15 Million
Q4 2017 Feb 05, 2018	SELL	$41.95 - $60.1 $218,140 - $312,520	-5,200 Closed	0 $0
Q3 2017 Nov 06, 2017	SELL	$33.4 - $53.9 $165,664 - $267,344	-4,960 Reduced 48.82%	5,200 $280,000
Q2 2017 Aug 09, 2017	BUY	N/A	10,160	10,160 $328,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $31.9M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.